iBio, Inc.
IBIO
$1.26
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -142.69% | -1.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -23.77% | -11.43% | |||
| Operating Income | 23.77% | 11.43% | |||
| Income Before Tax | -37.14% | 14.04% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -37.14% | 14.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -37.14% | 14.04% | |||
| EBIT | 23.77% | 11.43% | |||
| EBITDA | 24.21% | 11.68% | |||
| EPS Basic | -12.85% | 28.78% | |||
| Normalized Basic EPS | 40.35% | 28.75% | |||
| EPS Diluted | -12.85% | 28.78% | |||
| Normalized Diluted EPS | 40.35% | 28.75% | |||
| Average Basic Shares Outstanding | 21.53% | 20.65% | |||
| Average Diluted Shares Outstanding | 21.53% | 20.65% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||